The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Results of the prospective, randomized, and customized NSCLC adjuvant phase II trial (IFCT-0801, TASTE trial) from the French Collaborative Intergroup.
Jean-Charles Soria
Consultant or Advisory Role - Lilly; Roche
Research Funding - Lilly; Roche
Fabrice Barlesi
Consultant or Advisory Role - Roche
Honoraria - Lilly; Roche
Research Funding - Lilly; Roche
Benjamin Besse
No relevant relationships to disclose
Julien Mazieres
Honoraria - Lilly; Roche
Patrick Merle
No relevant relationships to disclose
Jacques Cadranel
Consultant or Advisory Role - Lilly; Roche
Honoraria - Lilly; Roche
Clarisse Audigier-Valette
No relevant relationships to disclose
Denis Moro-Sibilot
Consultant or Advisory Role - Lilly; Roche
Honoraria - Lilly; Roche
Laure Gautier-Felizot
No relevant relationships to disclose
Francois Goupil
No relevant relationships to disclose
Patrick Renault
No relevant relationships to disclose
Elisabeth A. Quoix
Consultant or Advisory Role - Lilly; Roche
Honoraria - Lilly; Roche
Pierre Jean Souquet
No relevant relationships to disclose
Anne Madroszyk
No relevant relationships to disclose
Romain Corre
No relevant relationships to disclose
David Pérol
No relevant relationships to disclose
Laurence Baudrin
No relevant relationships to disclose
Franck Morin
No relevant relationships to disclose
Gerard Zalcman
No relevant relationships to disclose
Marie Wislez
No relevant relationships to disclose